The effects on neuromuscular blockade by d-tubocurarine and succinylcholine of inhibition of prostaglandin.biosynthesis by indomethacin and of intra-arterial administration of prostoglandins Ez and FzMon a, before and after inhibition of prostoglandin biosynthesis, were evaluated in the cat sciatic-tibialis preparation.
chloralose I00 rag. kg -l. Following intubation of the trachea mechanical ventilation with air maintained arterial Pco2 at 4.0 to 4.5 kPa (30-35 torr) and Po2 at 11.3 to 12.7 kPa (85-95 torr). The tendon of the right anterior tibialis muscle was dissected free, sectioned near the point of osseous attachment and connected to a Grass FT-10 force displacement transducer. The right sciatic nerve was then sectioned and the distal peroneal nerve was isolated and supramaximal stimuli (1-8 volts) of 0.5 msec duration and 0.2 Hz were applied from a Grass stimulator, model S4G, through shielded platinum electrodes. The force of muscle contraction was recorded continuously on a Grass model 5 polygraph. The twitch tension exhibits only five per cent reduction from control over a three-hour period. The right femoral artery was exposed for intra-arterial drug administration. Body temperature was monitored and maintained at 36-38 ~ C. The left femoral artery was cannulated and connected to a Statham P23 Db arterial pressure transducer for continuous pressure and blood gas monitoring to ascertain cardiopulmonary stability.
Eight animals (Group l) received an intravenous bolus injection of d-tubocurarine 0.2 rag-kg -~ , followed by a continuous infusion of d-tubocurarine 100 gg/ml, through a Harvard infusion pump to produce 90 per cent twitch height depression. The 90 per cent twitch height 146 depression was maintained for 20 minutes before proceeding. A slow (5 minute) intra-arterial injection of either prostaglandin E2 0.5 mg (PGE2) (four animals), or F2alpha 0.5 mg (PGFz alpha) (four animals), was then given and the twitch height response was recorded. Another eight animals (Group 2) were treated the same as Group I, except that indomethacin 3 rag. kg -~ was given intravenously one hour before administration of the same dose of PGE2 (four animals) or PGF_~aI~h~ (four animals), lndomethacin powder was dissolved by titration with 0.1 N Na2COa after the method of Wilkerson and Glenn 3 Another eight animals (Group 3) received an intravenous bolus of succinylcholine 0.03-0.1 mg.kg -t adequate to depress twitch tension 60 to 80 per cent. During maximal twitch tension depression, 0.5 mg of either PGEz (four animals) or PGF2a~pha (four animals), was administered intra-arterially and the twitch height response recorded as above. Group 4 of eight animals were treated and studied in the same manner as Group 3, except that indomethacin, 3 rag. kg -~ was given intravenously one hour before administration of the prostaglandins.
In another eight animals (Group 5) four cats received d-tubocurare 0. I and 0.2 rag. kg -~ intravenously and four cats received succinylcholine, 0.03 and 0.06mg.kg -~ intravenously with the following parameters of neuromuscular function recorded: latency, maximal blockade obtained and time required for recovery to 90per cent of control twitch tension. Methodology employed has been previously reported. 4 A 45-minute period was allowed between the two doses of the neuromuscular blocking agent. The same animal was studied one week later as described, except that indomethacin 3 mg. kg -~ was given intravenously one hour before administration of the neuromuscular blocking agents.
Statistical significance was calculated using Student's t-test for paired or unpaired data. Differences with a probability of 0.05 or less were considered significant.
RESULTS
The latency period, maximum percent block obtained and time required to return to 90 per cent control twitch tension of neuromuscular blockade induced by d-tubocurarine and succinylcholine were not significantly altered by inhibition of prostaglandin biosynthesis induced by indomethacin (Table I) . In these animals, the administration of the indomethacin vehicle, (0. I N Na2CO3) produced no change in the control twitch tension.
Prostaglandin Ez antagonized neuromuscular blockade induced by d-tubocurarine by an average of 6 per cent (p > 0.05) before and 15 per cent (p < 0.05) after indomethacin but potentiated neuromuscular block induced by succinylcholine by an average of five per cent (p > 0.05) before and l0 per cent (p < 0.05) after indomethacin (Table 1I) .
PGF~a~pha antagonized neuromuscular blockade by d-tubocurarine by an average of 10 per cent (p < 0.05) before and 18 per cent (p < 0.05) (Table 11 ).
DISCUSSION
Our results show that the cat sciatic-tibialis preparation responded in a dose-related manner to the administration of d-tubocurarine or succinylcholine and the neuromuscular blocking actions were not influenced by prostaglandin synthetase inhibition. "Prostaglandin synthetase" is a multi-enzyme complex, apparently present in every mammalian tissue thus far investigated. 2 "Aspirin-like drugs", although of diverse chemical structure, possess antipyretie, analgesic and anti-inflammatory activity in the decreasing order of potency: indomethacin > phenylbutazone > aspirin or ibuprofen. 2 Therefore, indomethacin was selected as the prototype of the prostaglandin synthetase inhibitors. Wilkerson and Glenn 3 have previously demonstrated that, at the dosages used in this study, intravenous indomethacin 3 mg' kg-' intravenously will cause effective prostaglandin synthetase inhibition within 30 minutes of administration. Thus it seems that inhibition ofprostaglandin biosynthesis alone does not alter the action of neuromuscular blocking agents.
However, the intra-arterial administration of exogenous prostaglandins PGE2 and PGF2alph, antagonized d-tubocurarine and potentiated succinylcholine neuromuscular blockade, although only the combination of PGF2a,pha with dtubocurarine was statistically significant. These effects were greatly enhanced after indomethacin administration. These results would be compatible with increased neurotransmitter release at the neuromuscular junction induced by these two prostaglandins.
PGE~ and PGE2 have been reported to reduce adrenergic nerve terminal release of norepinephrine in the isolated rabbit heart, while PGF2 a~ph~ does not. ~' -~ Jansson et al. 6 have reported PGE~ to inhibit acetylcholine releasc in the rat phrenic nerve-diaphragm preparation. It seems apparent, then, that different classes of prostaglandins in different species may increase or decrease neurotransmitter release at nerve terminals in which either acetylcholine or norepinephrine is the neurotransmitter.
Many of the prostaglandins, in particular the E series, influence the tissue levels of 3', 5'-AMP. 7'8 It is currently thought that the E series prostaglandins activate membrane-bound adenyl cyclase activity, especially in myocardium, by stimulation of a receptor site other than the betaadrenergic receptor site; beta-blockade will not block this effect of the prostaglandins. ~ Standaert, et al. ' ~ recently demonstrated that activation of adenyl cyclase, inhibition of phosphodiesterase and/or dibutyryl cAMP administration, increased motor nerve terminal 3', 5'-AMP levels and increased neurotransmitter output in the cat. Prostaglandin E, produced similar effects. '0 Therefore, it appears that increases in nerve terminal Y, 5'-AMP induced pharmacologically may increase neurotransmitter release. These reports by other investigators are compatible with the data presented here. PGE~ has been shown to have no effect on the response of skeletal muscle to acetylcholine, '~ further suggesting that the effects of the prostaglandins are on transmitter release at the nerve terminal.
Our data imply greater neurotransmitter release induced by PGEz and PGF2a~pha after prostaglandin synthetase inhibition, since an increase in acetylcholine concentration at the neuromuscular junction is expected to antagonize the nondepolarizing blockade of d-tubocurarine, but to potentiate the depolarizing blockade of suceinylcholine. Samuelsson and Wennmalm': similarly observed that prostaglandin synthetase inhibition augmented release of norepinephrine from the isolated rabbit heart during sympathetic nerve stimulation, suggesting a prostaglandin-mediated control mechanism at the adrenergic nerve terminal. Prostaglandins may also modulate neurotransmitter release at the neuromuscular junction. It is possible that indomethacinmay promote aeetylcholine release by inhibiting the synthesis of prostaglandins that normally limit neurotransmitter release.
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